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AbstrACt
Introduction In low/middle-income countries with 
substantial HIV and tuberculosis epidemics, health services 
often neglect other highly prevalent chronic conditions, 
such as hypertension, which as a result are poorly 
managed. This paper reports on a study to assess the 
effect on hypertension management of lay health workers 
(LHW) working in South African rural primary healthcare 
clinics to support the provision of integrated chronic care.
Methods A pragmatic cluster randomised trial with a 
process evaluation in eight rural clinics assessed the effect 
of adding two LHWs supporting nurses in providing chronic 
disease care in each intervention clinic over 18 months. 
Control clinics continued with usual care. The main 
outcome measure was the change in the difference of 
percentage of clinic users who had elevated cardiovascular 
risk associated with high blood pressure (BP) before and 
after the intervention, as measured by two cross-sectional 
population surveys.
results There was no improvement in BP control among 
users of intervention clinics as compared with control 
clinics. However, the LHWs improved clinic functioning, 
including overall attendance, and attendance on the 
correct day. All clinics faced numerous challenges, 
including rapidly increasing number of users of chronic 
care, unreliable BP machines and cuffs, intermittent drug 
shortages and insufficient space.
Conclusion LHWs improved the process of providing 
care but improved BP control required improved clinical 
care by nurses which was compromised by large and 
increasing numbers of patients, the dominance of the 
vertically funded HIV programme and the poor standards of 
equipment in clinics.
trial registration number ISRCTN12128227.
IntroduCtIon
Low/middle-income countries are facing an 
increasing burden of chronic non-communi-
cable diseases, including a high prevalence of 
hypertension.1 In countries with high levels 
of HIV and tuberculosis (TB), the result is 
a considerable burden of care in primary 
healthcare clinics. In South Africa, the health 
service is managing the world’s largest HIV 
treatment programme,2 but hypertension, 
which is more prevalent than HIV, is poorly 
managed with low levels of awareness and 
control.3 4 In the Agincourt Health and 
Demographic Surveillance System (HDSS) 
site, based in rural north-east South Africa, 
around 57% of the adult population have 
high blood pressure (BP), but the condition 
is appropriately managed in less than 10%.5 
Primary healthcare clinics in South Africa 
are responsible for case finding, treatment 
and adherence support for patients with 
chronic diseases. In an effort to provide inte-
grated care for the large number of patients 
with chronic disease, services have recently 
been reorganised with appointment sched-
uling, preappointment retrieval of files and 
preparing medication prior to the patient’s 
appointment.6–8 The aim is to speed the 
journey for chronic patients through the 
clinic, improving efficiency, while ensuring 
chronic conditions are effectively controlled. 
A recently published review of these changes 
showed that nurses were struggling to 
carry out these tasks in addition to clinic 
consultations.9
Task shifting has been an important 
strategy in the provision of care for patients 
with HIV and TB.10 Lay counsellors provide 
counselling and testing services,11–14 and lay 
health workers (LHW) provide adherence 
support.15–17 We hypothesised that LHWs 
would be able to assist clinic staff with the 
administrative and education aspects of the 
newly reorganised integrated chronic care, 
allowing the nurses to focus on the clinical 
consultations and hence leading to improve 
health outcomes. In this paper, we report the 
results of a parallel cluster randomised trial 
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which tested a clinic-level intervention, shifting tasks 
from nurses to LHWs. We aimed to improve the manage-
ment of chronic conditions, specifically the management 
of hypertension.
MetHods
study setting
The trial was based in Bushbuckridge subdistrict in 
Mpumalanga Province, South Africa, where the MRC/
Wits Rural Public Health and Health Transitions 
Research Unit has been running the Agincourt HDSS 
since 1992.18 The Agincourt HDSS, covering an area of 
450 km2, includes 115 000 individuals living in approxi-
mately 20 000 households distributed in 32 villages. The 
area has high unemployment with more than 50% of 
men (aged between 25 and 54 years old) and more than 
20% of women (25–49 years old) migrating to urban 
areas for work for part of the year.19 Infrastructure has 
improved in the last few years, but there is still irregular 
water supply, electricity is unaffordable for many, and the 
schools and health facilities do not provide services of 
adequate quality.18
Ten primary healthcare facilities and three hospitals 
that are 25–60 km away from the site serve the local popu-
lation. The Department of Health piloted the provision 
of integrated chronic disease care (ICDM) in the Bush-
buckridge subdistrict, 2 years prior to the start of this 
study. It has since been rolled out to other provinces.
study design, randomisation and blinding
The study was a pragmatic cluster randomised controlled 
trial with repeated cross-sectional surveys.20 21 Each 
cluster was one clinic together with the population that 
it served. Clinics were included if they were located in 
the site, rather than on the periphery, and if the clinic 
manager consented to participate in the study (figure 1). 
A clinic located out of the study site was chosen as a pilot 
site, to learn lessons about implementing the interven-
tion prior to establishing it in the trial sites. Simple 1:1 
random allocation of the eight clinics was carried out 
at a public meeting in the presence of clinic staff and 
community members. Clinics’ names in sealed envelopes 
were drawn from a box by a community member. This 
transparent process facilitated understanding and trust 
in the randomisation. It was not possible to blind clinic 
staff or patients to the allocation. However, the primary 
outcome was measured using an encrypted data set, with 
no indication of which arm received the intervention.
usual care in the study site
On attending a clinic, each patient is assigned to one of 
two queues, one for patients with an ongoing chronic 
condition, another for the remaining patients. After 
obtaining his/her file, each patient has their temper-
ature, pulse, weight and BP measured at a ‘vital signs’ 
station. This is usually carried out by a junior (enrolled) 
nurse, before the patient is seen by a professional nurse, 
who diagnoses, prescribes and dispenses medication in a 
designated chronic care consultation room. The opera-
tion of the separate chronic disease pathway depends on 
sufficient staff and equipment to maintain two vital signs 
stations (one for each queue), to carry out the additional 
tasks (preappointment retrieval of files, appointment 
scheduling and predispensing of medication), and that 
patients come within a few days of their appointed day, 
otherwise prepacked medication has to be unpacked.
Intervention
The intervention consisted of two LHWs assigned to each 
clinic to support nurses in the management of patients 
with chronic disease. The LHWs, selected from the local 
community, had completed their secondary education 
but had had little further education. They were trained 
and supervised by an implementation manager, who was 
a local primary healthcare nurse, with a training quali-
fication. As part of the pragmatic design, the staff and 
supervisors of intervention clinics were able to decide 
which tasks the LHWs should do. All the intervention 
clinics chose to have the LHWs assisting with booking 
appointments, retrieving and filing patient files, and 
Key questions
What is already known about this topic?
 ► Systematic reviews have provided evidence of the effectiveness 
of lay health workers (LHW) in improving access to care, the 
quality of care, including screening for cardiovascular risk factors, 
reducing systolic blood pressure (BP), fasting blood glucose and 
weight, as part of community-based care.
 ► While there is systematic review of studies looking at the effect 
of task shifting, the focus was shifting prescribing from doctors to 
nurses, we found no trials looking at LHWs’ role in the provision of 
clinic-based integrated chronic care.
What are the new findings?
 ► The Nkateko study was the first randomised controlled trial to 
assess the role of LHWs in the provision of integrated chronic care.
 ► While we found no improvement in BP control, the LHWs improved 
clinic attendance.
 ► A large and increasing numbers of patients, the dominance of 
the vertically funded HIV programme and the poor standards of 
equipment in clinics compromised the quality of clinical care 
provided by nurses.
 ► Assistance from LHWs with booking appointments, sending 
reminders, prepacking medication and providing health education 
was insufficient to improve BP control in this environment.
recommendations for policy
 ► Our results, taken together with the existing evidence, suggest 
that LHWs can play an important role in supporting the provision of 
integrated chronic care.
 ► However, adding additional human resources (even if readily 
available and relatively inexpensive) is unlikely to have an 
effect on health outcomes, without the necessary equipment to 
accurately measure BP, and sufficient clinical staff to  
treat the growing numbers of chronic patients.
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providing health education (on adherence and lifestyle). 
They also all chose to have the LHWs taking measure-
ments in the vital signs queue and assisting the nurses 
with the prepacking of medications. Some clinics strug-
gled to find space for these activities to take place, so the 
LHWs often had to operate in the corridor or the recep-
tion area. In addition, the LHWs phoned or sent a text 
message to patients with hypertension to remind them 
of their appointment. The implementation manager 
ensured fidelity to the planned intervention. The four 
control clinics continued working as normal and the 
implementation manager did not visit them or interact 
with their staff to avoid contamination.
In the first months of the intervention, the implementa-
tion manager found that none of the intervention clinics 
had cuffs in good repair for the electronic BP machines. 
Without the possibility of correctly measuring BP the 
intervention had little chance to be effective. Thus, 
although this was a pragmatic trial, we decided that it 
was necessary to replace the cuffs. To keep the compar-
ison meaningful, we provided both the intervention and 
control clinics with two new sets of cuffs. We originally 
planned the intervention to last for 15 months, but after 
having replaced the cuffs, we extended the intervention 
period for a further 3 months, up to 18 months in total.
Primary and secondary outcomes
Our primary outcome was based on the South African 
guidelines for the management of hypertension, which 
call for a focus on people at moderate or greater cardi-
ovascular risk.22 The primary outcome is defined as the 
difference (between intervention and control clinics) 
in the change of the proportion of the population who 
have uncontrolled hypertension together with a risk 
profile indicating at least moderate risk of cardiovascular 
disease (CVD).20 We did not have the resources to make 
the clinical diagnoses called for in the guidelines and 
used proxy measures for some items. For example, we 
collected data on self-reported stroke rather than making 
a diagnosis, and we used waist circumference as a proxy 
measure of obesity. The participants whose data were 
used to calculate the outcome measures were the self-de-
fined users of one of the eight clinics. As there were no 
records of who attended a clinic, and individuals are free 
to attend any clinic they choose, we asked respondents 
Figure 1 Allocation of clinics.
 o
n
 23 M
ay 2018 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2017-000577 on 15 February 2018. Downloaded from 
4 Goudge J, et al. BMJ Glob Health 2018;3:e000577. doi:10.1136/bmjgh-2017-000577
BMJ Global Health
which was their usual clinic and which clinic they visited 
last. For the large majority of respondents the usual clinic 
was the same as the last clinic. We used the usual clinic for 
the analysis of the primary outcome.
Our secondary outcomes are listed in box 1. The 
first five were derived from the two population surveys, 
while the last two came from the data we collected from 
patients as they entered the clinics, and from their clinic 
files. Data for the fifth outcome were not collected, as the 
time frame of 1 year was omitted from the survey ques-
tionnaire. There was some delay in setting up the system 
for collecting clinic data; as a result, the last two outcomes 
are reported for the period May 2014 to July 2015.
baseline and end of intervention cross-sectional surveys
For the two surveys, a separate random weighted sample of 
people over 18 years was drawn from the Agincourt census 
database with no knowledge of which, if any, clinic individ-
uals used. In the first survey, no other eligibility criterion was 
used. In the second survey, we excluded from the sampling 
frame individuals who had recently been randomly selected 
to participate in another research study that demanded a lot 
of participants’ time. The sample was weighted to provide 
larger numbers of older people, who could be expected 
to have a higher prevalence of hypertension. Informed 
consent was sought from each participant and refusals are 
reported in figure 2.
Fieldworkers were trained for 2 weeks before the survey. 
As the fieldworkers lived in the community it was not 
possible to blind them to which clinics received the inter-
vention. However, they had no involvement in either the 
implementation or the process evaluation. The question-
naire was piloted in advance. Quality control included 
three stages in the first survey: a supervisor checked 
the completed questionnaires in the field; the project 
manager checked them as he filed them in the office; and 
the data manager checked them prior to data entry. In 
the second survey, we included an additional check of a 
random 5% of interviews for which a supervisor returned 
to the household a few days later and reinterviewed the 
participant to confirm responses to some selected ques-
tions. A double entry data system was used and a data 
manager made the comparison of the two entries and 
corrected those where there was a discrepancy using the 
paper questionnaire as a reference.
The questionnaire included self-reported history of 
hypertension, diabetes, stroke, heart failure, angina and 
heart attacks, smoking, clinic use (last and usual) and 
family history of CVD. We did not attempt to measure the 
number of cigarettes smoked as regular heavy smoking 
is unusual in this cash-poor community. Information on 
age, gender, marital status, education and socioeconomic 
status was drawn from the census database.
Variable measurement and definitions
Pulse, systolic and diastolic BP was measured three times 
in a seated position after 5 min of rest and with 2 min 
interval using the OMRON M6W automated cuff (Omron, 
Kyoto, Japan). Waist circumference was measured using 
a flexible tape measure (SECA). A finger prick was used 
to measure random blood glucose (CareSens N Monitor) 
and total cholesterol (CardioChek PA Silver version).
We derived the mean systolic and diastolic BP using the 
average of the second and third BP measurements. We 
defined diabetes as a random glucose measure of over 
11 mmol/L. A person with a random glucose measure 
between 7 and 11 mmol/L, and who reported that they 
had not eaten for 12 hours, was recorded as having high 
blood glucose. The remaining respondents were consid-
ered not to be diabetic. We defined obesity as a waist 
circumference greater than 94 cm in men or greater than 
80 cm in women.22
We estimated the time that patients spent in the 
clinics by calculating the difference between the time 
the patients reported arriving at the clinics and the time 
of the exit interviews, as described under the Process 
evaluation section.
Clinic activity data
To collect data on clinic activity, an experienced data entry 
clerk sat with a laptop in each control and intervention clinic 
for the period of the intervention. A unique record using 
identifiers (ID numbers, cellphone, date of birth, gender, 
village of residence and the name of another person in the 
household) was created for each consenting individual, and 
the date of visit, diagnosis and date of return visit were then 
collected from the clinic records for this and all subsequent 
visits by that individual.23
sample size
We derived our assumptions for the sample size calcula-
tion from data collected in the same site in 2010.24 We 
adopted the use of the coefficient of variation (SD of 
the cluster means divided by the overall mean) as used 
Box 1 secondary outcomes of the trial as reported in this 
paper
secondary outcomes derived from population surveys
1. Changes in the proportion of the population at different levels of 
blood pressure-related cardiovascular risk by age group and sex.
2. Change in proportion of the population with undiagnosed 
hypertension.
3. Change in the proportion of the population reporting they had had 
their blood pressure measured.
4. Change in the proportion of the population reporting that they are 
using medication for hypertension.
5. Change in the proportion of people in the population reporting that 
they have attended a clinic in the last year. Listed in the analysis 
plan but not collected.
secondary outcomes derived from clinic activity data
6. Retention in care of people with diagnosed hypertension defined 
by the proportion of appointments kept during the study period.
7. The number of clinic visits per month related to a diagnosis of 
hypertension. Not listed in the analysis plan but used to replace 
secondary outcome no. 5 above.
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in similar study settings when we cannot get a good 
intracluster variation25–27 and assumed that the coeffi-
cient of variation would be similar in the two groups 
and that effects of the interventions would be similar 
across clusters. We used a background prevalence of 
36% and a coefficient of variation of 0.132 (95% CI 
0.087 to 0.177). We assumed that the two population 
surveys would each include at least 4000 participants, 
with approximately 500 people in each of the eight 
clusters. We estimated that we would have 88% power 
to detect a reduction of 11% (from 36% to 25%) in 
people at moderate or greater cardiovascular risk.
statistical methods
Sociodemographic and clinical information including 
both primary and secondary outcomes was summarised 
using frequencies and summary measures. Continuous 
variables such as age and BP levels were summarised 
using the mean and SD. Categorical variables such as 
gender were described through frequency tabulations 
by reporting the relative percentage and the number of 
observations (%, n).
The analysis of the primary outcome was conducted 
to test the difference in the change in the proportions 
with moderate or greater added risk of CVD in the 
Figure 2 Response to survey by individuals sampled.
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intervention and control clusters. We used the cluster 
adjusted Pearson’s χ2 to adjust for clustering for each 
group. This analysis was carried out in EXCEL with user 
written commands. All other analyses were done using 
STATA V.14 (StataCorp, 2015. Stata Statistical Software: 
Release 14. College Station, TX: StataCorp) and statis-
tical significance was considered at 5% level.
We included the following sensitivity analyses for the 
primary outcome: (A) an analysis which included those 
who did not name any specific drugs when reporting on 
hypertensive drugs (in the primary analysis these indi-
viduals were not included as having hypertension); (B) 
an analysis using the ‘last’ clinic rather than the ‘usual’ 
clinic to assign individuals to clinics; (C) an analysis using 
two-stage regression modelling instead of the adjusted χ2; 
and (D) an analysis using mixed effects model adjusting 
for covariates. Secondary outcomes were analysed in the 
same way as the primary outcome. No sensitivity analyses 
were conducted.
Process evaluation
We conducted a theory-driven, mixed methods eval-
uation to understand the causal processes that led to 
change (or not).20 We observed clinic activity, the move-
ment of patients along the clinic pathway and patient 
consultations over a period of 3–9 days at 6-month inter-
vals (control and intervention) during the 18-month 
intervention period. We conducted brief exit interviews 
with the patients as they left the clinic (n=703). We 
also conducted bimonthly interviews with the LHWs 
throughout the intervention, as well as interviews with 
clinic staff, and clinic and district managers.
The clinic managers of all the clinics taking part in the 
trial consented for their clinic staff to participate and 
all individuals interviewed in the population surveys or 
process evaluation gave written informed consent to the 
interview.
role of funding source
The funder had no involvement in the study.
results
The baseline population survey collected information on 
3978 people, with a response rate of 84.2% (3978/4722) 
(figure 2). After excluding 44 questionnaires that were 
completed by a fieldworker who was later found to be 
unreliable, 145 respondents who reported that they did 
not use any public clinic and a further 376 respondents 
who used a clinic that was not one of the trial clinics, 
3413 questionnaires were included in the analysis. The 
end of intervention survey had a response rate of 80.3% 
(3184/3965) (figure 2). After excluding those who 
reported that they did not use public clinics (97) and 
those who did not use one of the trial clinics (548), 2539 
questionnaires were included in the analysis.
There were no important differences in sociode-
mographic or health variables between the control 
and intervention groups (table 1). Just under half of 
the respondents were found to have hypertension. In 
6%–10% the hypertension was controlled on treatment, 
9%–13% were on treatment but the hypertension was 
not controlled, and between 20% and 30% of the respon-
dents had hypertension but were not on treatment. As is 
common in the black South African population, obesity 
was more prevalent in women than men. There are fewer 
men aged over 80 years in the second survey because we 
excluded individuals who had just participated in another 
research study. This resulted in a very small sampling 
frame for this small group of men, and so we selected for 
interview all the available men.
When we planned the study, we were concerned that 
many individuals might move between intervention and 
control clinics and so we asked respondents which was 
their usual clinic and which was the last clinic they used. 
We found that less than 3.5% of individuals had switched 
between intervention and control clinics (see online 
supplementary table 1).
Primary and secondary outcomes
There was no evidence of an effect of the intervention 
in the primary outcome or in the first four secondary 
outcomes that were derived from the population surveys 
(table 2). None of the sensitivity analyses altered this 
conclusion. There was no evidence of a reduction in those 
with moderate or greater CVD risk (OR 1.13, 95% CI 0.83 
to 1.54). The 95% CI excluded the OR of 0.59 given by the 
clinically important difference in our sample size calcula-
tion, providing very strong evidence that the intervention 
as delivered could not have achieved the desired change. 
By the end of the intervention, three quarters of patients 
with hypertension were attending the intervention clinics 
on the day of their appointment, compared with 56% in 
control clinics (figure 3), suggesting improved adher-
ence.
All clinics experienced an increase in the number of 
visits by patients with a chronic condition (figure 4) (anal-
ysis of variance coefficient 53.3; P<0.01). The number 
of visits in control clinics was similar for those with and 
without hypertension. However, in the intervention 
clinics the number of visits by chronic patients (with and 
without hypertension) was greater than in the control 
clinics (figure 4). In particular, there were a significantly 
greater number of hypertension visits than other chronic 
condition visits in the intervention clinics (analysis of 
variance for patient with hypertension coefficient 1295; 
P<0.01, chronic conditions coefficient 463; P<0.01).
Process evaluation
The almost doubling of the number of patients with a 
chronic disease attending the clinics over the 18 months 
of the study, with no matching increase in equipment 
or space, resulted in both control and intervention 
clinics facing numerous challenges. These included BP 
machines that often failed to function, worn out cuffs, 
intermittent shortages of drugs and insufficient space 
for the increasing numbers of patients. The cuffs that we 
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replaced early on in the trial were worn out before the 
end of the intervention. There was no routine servicing 
of the BP machines, and when they were taken for repair, 
they could be away from the clinic for several months. 
Sometimes a clinic only had functioning mercury sphyg-
momanometers, which the nurses were reluctant to use 
because of the time involved and the discomfort of using 
stethoscopes for several hours at a time. Table 3 provides 
Table 1 Sociodemographic and health variables in the baseline and end of intervention surveys
Control Intervention
Baseline survey
n=1908
End of intervention 
survey
n=1430
Baseline survey
n=1505
End of intervention 
survey
n=1109
Mean age (SD) 56.4 (19.8) 52.7 (19.7) 56.8 (18.9) 53.0 (19.2)
% (n) % (n) % (n) % (n)
Female 56.0 (1068) 70.5 (1008) 55.1 (829) 68.7 (762)
In a marital union 48.2 (919) 39.5 (565) 49.0 (737) 40.1 (445)
Education 
  No education 40.6 (772) 37.2 (530) 38.4 (576) 32.3 (357)
  Primary 25.4 (483) 21.7 (310) 25.4 (381) 21.9 (242)
  Secondary 30.9 (588) 38.6 (550) 31.9 (479) 40.7 (451)
  Tertiary 3.1 (58) 2.5 (36) 4.4 (66) 5.2 (57)
Socioeconomic status 
  1 (lowest) 18.8 (326) 23.7 (335) 16.6 (229) 14.8 (164)
  2 20.1 (348) 20.7 (292) 18.3 (253) 18.9 (209)
  3 19.2 (332) 18 (254) 19 (263) 20.7 (229)
  4 19.4 (335) 19.6 (277) 20.8 (288) 20.8 (230)
  5 (highest) 22.5 (390) 18.1 (256) 25.4 (351) 24.7 (273)
Smoking history 
  Never smoked 79.3 (1507) 84.9 (1214) 76.8 (1151) 85.8 (952)
  Previous smoker 11.3 (214) 5.6 (80) 13.4 (201) 7 (78)
  Smokes <1/day 2.3 (44) 2 (29) 2.4 (36) 1.6 (18)
  Smokes >1/day 7.2 (136) 7.5 (107) 7.4 (111) 5.5 (61)
Self-reported health and risk 
  Family history of CVD 8.3 (158) 10.4 (148) 7.4 (111) 6.1 (68)
  Diabetes 6.5 (124) 6.9 (99) 6.2 (93) 5.8 (64)
  Coronary heart disease 4.2 (81) 1.6 (23) 1.9 (29) 2.5 (28)
  Stroke or TIA 3.2 (61) 3.2 (46) 2.6 (39) 1.6 (18)
  Heart failure 2.8 (53) 1.5 (21) 2.4 (36) 1.2 (13)
Obesity 
  Male (waist >94 cm) 26.3 (221) 20.4 (86) 31.1 (210) 30.3 (105)
  Female (waist >80 cm) 80.2 (857) 78.5 (791) 81.4 (675) 77.3 (589)
Hypertension 
  No hypertension 53.7 (1024) 52.9 (757) 53.0 (797) 50.9 (564)
  On treatment and controlled 10.2 (194) 11.2 (160) 6.6 (100) 11.3 (125)
  On treatment but not controlled 9.2 (175) 13.2 (189) 8.8 (133) 13.0 (144)
  Not on treatment 27.0 (515) 22.7 (324) 31.6 (475) 24.9 (276)
Blood glucose 
  Normal <11, not fasting 91.5 (1745) 92.7 (1325) 91.4 (1375) 92.1 (1021)
  High 7 <11, fasting 0.7 (13) 0.9 (13) 0.3 (4) 0.8 (9)
  Diabetic 11 or more 7.8 (149) 6.4 (92) 8.4 (126) 7.1 (79)
CVD, cardiovascular disease; TIA, transient ischaemic attack. 
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Table 2 Comparison of primary and secondary outcomes at end of intervention by study arm
Control
n=1414
Intervention
n=1094 Estimated 
ICC
Adjusted OR
(95% CI)
Adjusted χ2 
statistics P value% (n) % (n) 
CVD risk 
  No or low 74.1 (1048) 73.2 (801) 0.006 1.13 (0.83 to 1.54) 0.076 0.782
  Moderate or higher 25.9 (366) 26.8 (293)
Gender 
  Female
   No or low 74.2 (742) 74.8 (564) 0.004 1.00 (0.75 to 1.34) 0.039 0.844
   Moderate or higher 25.8 (258) 25.2 (190)
  Male
   No or low 73.9 (306) 69.7 (237) 0.013 1.32 (0.85 to 2.04) 0.59 0.443
   Moderate or higher 26.1 (108) 30.3 (103)
Age 
  18–29 years
   No or low 99.0 (188) 95.9 (117) 0.183 22.5 (0.122 to 4.144) 0.3 0.584
   Moderate or higher 1.1 (2) 4.1 (5)
  30–39 years
   No or low 90 (206) 89.6 (173) <0.001 1.04 (0.55 to 1.95) 0.012 0.914
   Moderate or higher 10 (23) 10.4 (20)
  40–49 years
   No or low 87.2 (224) 84.8 (167) <0.001 1.22 (0.72 to 2.08) 0.532 0.466
   Moderate or higher 12.8 (33) 15.2 (30)
  50–59 years
   No or low 75.1 (148) 77.3 (136) 0.004 0.88 (0.50 to 1.54) 0.186 0.666
   Moderate or higher 24.9 (49) 22.7 (40)
  60–69 years
   No or low 67.3 (142) 68.0 (106) 0.012 0.97 (0.62 to 1.51) 0.01 0.92
   Moderate or higher 32.7 (69) 32.0 (50)
  70–79 years
   No or low 44.1 (82) 47.4 (64) 0.037 0.88 (0.43 to 1.77) 0.125 0.723
   Moderate or higher 55.9 (104) 52.6 (71)
  80+ years
   No or low 40.3 (58) 33.0 (38) <0.001 1.37 (0.82 to 2.28) 1.435 0.231
   Moderate or higher 59.7 (86) 67.0 (77)
Hypertension diagnosis 
  Undiagnosed 22.1 (312) 24.1 (264) 1.12 (0.93 to 1.35)
  None or diagnosed 77.9 (1102) 75.9 (830) <0.001 1.489 0.222
BP ever measured 
  No 5.7 (80) 9.1 (100) 0.014 0.71 (0.29 to 1.73) 1.729 0.188
  Yes 94.3 (1334) 90.7 (994)
Taking medication for hypertension 
  No 75.6 (1069) 75.7 (828) 0.024 1.21 (0.70 to 2.09) 0.002 0.988
  Yes 24.4 (345) 24.3 (266)
BP, blood pressure; CVD, cardiovascular disease; ICC, intraclass correlation. 
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a description of the state of the BP machines for different 
periods of the study.
Despite these challenges, there were signs of improve-
ment in the provision of care. The LHWs were encour-
aged to support the nurses in identifying undiagnosed 
hypertension among patients attending for other 
reasons. In the intervention clinics, 760 patients without 
a diagnosis of hypertension were identified with high BP 
and half of them (40%, 301 individuals) subsequently 
received a diagnosis of hypertension during the 18 
months. Data from patient exit interviews suggest that 
waiting times may have been reduced in the intervention 
clinics (table 4).
dIsCussIon
We aimed to improve the management of hypertension 
by providing extra support from LHWs to the nurses who 
are responsible for the management of chronic condi-
tions in primary care clinics. We found no evidence of an 
improvement in the management of hypertension as a 
result of our intervention. However, we did find improve-
ments in the functioning of the intervention clinics in 
a number of important ways, including patients keeping 
their appointments, and more patients with hypertension 
returning to the clinics.
This was a pragmatic trial, designed to test an interven-
tion that was both affordable and sustainable in a sub-Sa-
haran Africa context. Using the precis-2 tool, we (JG, MT) 
assessed that the trial had a score of 41 out of 45, where 45 
is the most pragmatic.28 We aimed to only provide those 
parts of an intervention which, if effective, could conceiv-
ably be funded by the South African Health budget. We 
provided some training for the nurses, and the implemen-
tation manager tried to assist in getting the BP machines 
Figure 3 Number of monthly clinic visits by patients with hypertension and other chronic conditions in the control and 
intervention clinics. 
Figure 4 Percentage of patients who attend the clinic on their appointed day by month. 
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repaired using the normal systems. However, we did not 
supply extra BP machines. We did supply replacement cuffs 
for existing machines, but supplied these to both interven-
tion and control clinics. Moreover, in keeping with the 
pragmatic nature of the trial, and to encourage clinic staff 
to feel ownership of the intervention, the ways in which the 
LHWs would support chronic disease care were decided 
separately in each clinic by the clinic staff.
The trial was based on a strong research platform 
provided by the HDSS which allowed us to carry out strati-
fied random sample surveys and also to collect information 
on clinic activity. The population surveys, which measured 
the BP control of respondents who usually used the study 
clinics, were designed to identify a change in the numbers 
accessing treatment for hypertension as well as a change 
in BP control. However, this measure included those who 
might not have attending the clinic as regularly as they 
should have been, reducing our chances of identifying the 
effect of improved care on BP control among those who 
attended a clinic regularly. (Alternative study designs were 
not possible: existing clinic records were not sufficiently 
reliable; intervening to strengthen the current filing system 
would have reduced the pragmatic nature of the trial; and 
setting up a study measuring station for each clinic was 
not affordable.) Moreover, as there were only eight clinics 
in the HDSS we were limited in the number of possible 
clusters.
Through the implementation manager we were able 
to ensure fidelity to the planned intervention as well as 
sufficient flexibility to the local context. We were also 
careful to separate implementation and evaluation activi-
ties. It is possible that the activity of the trial contributed 
to improved performance in the control clinics. We had 
a data entry clerk in all the control clinics who collected 
information about clinic users and, inevitably, contrib-
uted to the management of the clinic files, and therefore 
relieved nurses of some routine tasks. However, we do not 
think this possible contamination was sufficient to reduce 
a difference between control and intervention outcomes.
The lack of effect in BP control may be due to the poor 
condition of the BP machines and cuffs, and that both the 
intervention and the control clinics were overwhelmed by a 
rapid increase in numbers of chronic patients. This increase 
was due both to the continuing roll-out of antiretrovirals 
Table 3 Description of the state of the BP machines from observations and interviews
Study period Intervention clinics Control clinics
January to June 2014  ► Two clinics stopped using electronic 
machines due to faulty cuffs and used 
manual machines.
 ► In one clinic the machine did not function 
properly and readings were unreliable.
 ► Generally all electronic BP machines were 
functioning well.
 ► Although all cuffs were wearing out.
Cuffs for electronic machines provided to all clinics
July 2014 to March 2015  ► Cuffs for manual machines were still a 
problem.
 ► Electronic machines themselves began to 
develop problems as a result of overuse.
 ► Little information in this period
April 2015 to August 2015  ► Problems with the electronic BP machines 
increased (with the on/off button not working, 
or the machine not clearing the data in 
preparation for the next patient).
 ► At the end of the period three of the four 
intervention clinics had their machines sent 
for repair.
 ► Clinic managers had little hope of getting 
them back soon.
 ► Cuffs supplied by study had started wearing 
out.
 ► Early in this phase one clinic sent its 
machines for servicing, but it was not 
returned by the end of study.
 ► Two clinics doubted the accuracy of 
readings and used a manual machine to 
confirm a high reading.
 ► Cuffs supplied by study had started wearing 
out.
BP, blood pressure.
Table 4 Mean time in hours spent by patients with hypertension in clinics derived from exit interviews
Control Intervention
Phase 1
March to July 
2014
Phase 2
November to 
March 2015
Phase 3
June to August 
2015
Phase 1
March to July 
2014
Phase 2
November to 
March 2015
Phase 3
June to August 
2015
Mean (SD) 3.67 (1.77) 3.96 (1.17) 3.60 (1.29) 3.30 (1.22) 3.07 (0.99) 2.41 (1.16)
n 49 105 95 126 88 95 
 o
n
 23 M
ay 2018 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2017-000577 on 15 February 2018. Downloaded from 
Goudge J, et al. BMJ Glob Health 2018;3:e000577. doi:10.1136/bmjgh-2017-000577 11
BMJ Global Health
for HIV and a hospital policy of referring outpatients back 
into primary care. In the intervention clinics, there was a 
further increase in patients with hypertension attending 
the clinic, most probably due to the intervention itself.
An earlier study of the ICDM initiative in the same clinics 
demonstrated that management of HIV was more effec-
tive than management of BP: less than 50% of the patients 
attending the clinic had controlled BP, nearly 90% of patients 
with HIV had a controlled CD4 count.9 28 29 South Afri-
ca’s HIV programme is vertically organised, with generous 
funding and a separate management structure, requiring 
more detailed reporting from primary care clinics. It may 
be that this also continued to distort the work in the clinics, 
despite attempts to integrate the provision of care; with no 
requirement to report patient outcomes for hypertension 
there is insufficient emphasis on improving clinical care.30
Systematic reviews of randomised trials have concluded 
that community health workers are effective in improving 
health and treatment outcomes,31 the included studies 
predominately focus on a single condition or health 
outcome (breast feeding, immunisation, TB cure rates), 
rather than the provision of integrated care. Moreover, the 
health outcomes measured are often those achieved by the 
community health worker alone, rather than outcomes 
requiring the contribution of other healthcare workers, as 
in this study. We found only one systematic review of studies 
looking at the effect of task shifting, which focused only 
on shifting prescribing from doctors to nurses.32 As far as 
we are aware, the Nkateko study was the first randomised 
controlled trial to assess the supportive role of LHWs in the 
management of hypertension in the context of clinic-based 
integrated chronic care.
ConClusIon
Our intervention did not improve BP control, despite its 
success in increasing the number of patients with hyper-
tension attending the clinic, as well as the number that 
attended on their appointed day. We believe that the study 
was compromised by the large and increasing demands 
on primary care, the dominance of the vertically funded 
HIV programme and the poor standards of equipment 
in clinics. However, as this study shows, adding additional 
human resources (even if readily available and rela-
tively inexpensive) is unlikely to have an effect on health 
outcomes, without the necessary equipment to accurately 
measure BP, and sufficient clinical staff to treat the growing 
numbers of chronic patients. To be successful, task shifting 
interventions need to take account of all aspects of the 
patient encounter, and if possible other system-wide contex-
tual changes (such as rapidly increasing patients). Our 
results, taken together with the existing evidence, suggest 
that LHWs can play an important role in supporting the 
management of hypertension.
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